Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
Parkinson's is a brain condition which is responsible for uncontrolled movements. It causes difficulty in talking, walking, ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was associated with reduced incidence of Parkinson’s disease, data show.“This ...
People with Parkinson's disease are more likely to develop certain types of dementia. Find out about the causes, symptoms and treatments. Parkinson’s disease is a brain disease that affects around 145 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback